Evaluation of an AAV2-based rapamycin-regulated glial cell line-derived neurotrophic factor (GDNF) expression vector system.
Effective regulation of transgene product in anatomically circumscribed brain tissue is dependent on the pharmacokinetics of the regulating agent, the kinetics of transcriptional activation and degradation of the transgene product. We evaluated rapamycin-regulated AAV2-GDNF expression in the rat bra...
Main Authors: | Piotr Hadaczek, Janine Beyer, Adrian Kells, Wade Narrow, William Bowers, Howard J Federoff, John Forsayeth, Krystof S Bankiewicz |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3221672?pdf=render |
Similar Items
-
Glial-derived neurotrophic factor gene transfer for Parkinson's disease: Anterograde distribution of AAV2 vectors in the primate brain
by: Adrian P. Kells, et al.
Published: (2012-11-01) -
Carbidopa-based modulation of the functional effect of the AAV2-hAADC gene therapy in 6-OHDA lesioned rats.
by: Agnieszka Ciesielska, et al.
Published: (2015-01-01) -
Axon guidance of sympathetic neurons to cardiomyocytes by glial cell line-derived neurotrophic factor (GDNF).
by: Keiko Miwa, et al.
Published: (2013-01-01) -
Glial cell line-derived neurotrophic factor (GDNF) as a novel candidate gene of anxiety.
by: Eszter Kotyuk, et al.
Published: (2013-01-01) -
Widespread AAV1- and AAV2-mediated transgene expression in the nonhuman primate brain: implications for Huntington's disease
by: Piotr Hadaczek, et al.
Published: (2016-01-01)